The effect of modulation of γ-glutamyl transpeptidase and nitric oxide synthase activity on GSH homeostasis in HepG2 cells

Fundamental and Clinical Pharmacology

Volumn 21, Issue 1, 2007, Pages 95-103

  Kwiecień, Inga ^a   Rokita, Hanna ^a   Lorenc Koci, Elzbieta ^b   Sokolowska, Maria ^a   Włodek, Lidia ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

1,2,3,4 tetrahydroisoquinoline; Acivicin; Aminoguanidine; Cytotoxicity; Glutathione; Human hepatoblastoma cells

Indexed keywords

ACIVICIN; ACYLTRANSFERASE INHIBITOR; AMINOGUANIDINE; BROXURIDINE; CASPASE 3; CISPLATIN; DOXORUBICIN; GAMMA GLUTAMYLTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE INHIBITOR; GLUTATHIONE; LACTATE DEHYDROGENASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TETRAHYDROISOQUINOLINE; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HEPATOBLASTOMA; HOMEOSTASIS; HUMAN; HUMAN CELL; MODULATION; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CASPASE 3; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CISPLATIN; DOXORUBICIN; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE; GLUTATHIONE DISULFIDE; HOMEOSTASIS; HUMANS; ISOXAZOLES; NITRIC OXIDE SYNTHASE; TETRAHYDROISOQUINOLINES;

EID: 33846245015     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2006.00458.x     Document Type: Article

References (45)

1. Wu G., Fang Y.Z., Yang S., Lupton J.R., Turner N.D. Glutathione metabolism and its implication for health. J. Nutr. (2004) 134 489-492.
2. Townsend D.M., Tew K.D., Tapiero H. The importance of glutathione in human disease. Biomed. Pharmacother. (2003) 57 145-155.
3. Pastore A., Federici G., Bertini E., Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin. Chim. Acta (2003) 333 19-39.
4. Huang Z.Z., Chen C., Zeng Z. et al. Mechanism and significance of increased glutathione level in human hepatocellular carcinoma and liver regeneration. FASEB J (2001) 15 19-21.
5. Hanigan M.H. c-Glutamyl transpeptidase, a glutathionase: its expression and function in carcinogenesis. Chem. Biol. Interact. (1998) 111-112 333-342.
6. Meister A. New developments in glutathione metabolism and their potential application in therapy. Hepatology (1984) 4 739-742.
7. Lee Y.Y., Kim H.G., Jung H.I. et al. Activities of antioxidant and redox enzymes in human normal hepatic and hepatoma cell lines. Mol. Cell (2002) 14 305-311.
8. Hanigan M.H, Frierson H.F., Swanson P.E., De Young B.R. Altered Expression of c-glutamyl transpeptidase in human tumors. Hum. Pathol. (1999) 30 300-305.
9. Lander H.M. An essential role for free radicals and derived species in signal transduction. FASEB J. (1997) 11 118-124.
10. Paolicchi A., Dominici S., Pieri S., Maellaro E., Pompella A. Glutathione catabolism as a signaling mechanism. Biochem. Pharmacol. (2002) 64 1027-1035.
11. 2 production, cell surface protein thiol oxidation and NF-κB activation status. J. Cell Sci. (2000) 113 2671-2678.
12. Corti A., Paolicchi A., Franzini M., Dominici S., Casini A., Pompella A. The S-thiolating activity of membrane c-glutamyltransferase: formation of cysteinyl-glycine mixed disul-fides with cellular proteins and in the cell microenviroment. Antioxid. Redox Signal. (2005) 7 911-918.
13. 2 production and S-thiolation. Free Rad. Biol. Med. (1999) 27 623-635.
14. Townsend D.M., Tew K.D. The role of glutathione S-transferase in anticancer drug resistance. Oncogene (2003) 22 7369-7375.
15. Patel R.P., Levonen A.L., Crawford J.H., Darley-Usmar V.M. Mechanism of the pro- and anti-oxidant actions of nitric oxide in artherosclerosis. Cardiovasc. Res. (2000) 47 465-474.
16. Huseby N.E., Asare N., Wetting S., Mikkelsen I.M., Mortensen B., Wellman M. Role of γ-glutamyltransferase in the homeostasis of glutathione during oxidative and nitrosative stress. Biofactors (2003) 17 151-160.
17. Moellering D., McAndrew J., Patel R.P. et al. The induction of GSH synthesis by nanomolar concentrations of NO in endothelial cells: a role for gamma-glutamylcysteine synthetase and gamma-glutamyl transpeptidase. FEBS Lett. (1999) 448 292-296.
18. Li H., Marshall Z.M., Whorton A.R. Stimulation of cystine uptake by nitric oxide: regulation of endothelial cell glutathione levels. Am. J. Physiol. (1999) 276 C803-C811.
19. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal. Biochem. (1969) 27 502-522.
20. Finkel T. Oxidant signals and oxidative stress. Curr. Opin. Cell. Biol. (2003) 15 247-254.
21. Pierce R.H., Campbell J.S., Stephenson A.B. et al. Distruption of redox homeostasis in tumor necrosis factor-induced apoptosis in a murine hepatocyte cell line. Am. J. Pathol. (2000) 157 221-236.
22. Ghezzi P., Bonetto V., Fratelli M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid. Redox Signal. (2005) 7 964-972.
23. Del Bello B., Paolicchi A., Comporti M., Pompella A., Maellaro E. Hydrogen peroxide produced during γ-glutamyl transpeptidase activity is involved in prevention of apoptosis and maintainance of proliferation in U937 cells. FASEB J. (1999) 13 69-79.
24. Ohta S., Kohno M., Makino Y., Tachikawa O., Hirobe M. Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline are present in the human brain: relation to Parkinson's disease. Biomed. Res. (1987) 8 453-456.
25. Makino Y., Ohta S., Tachikawa O., Hirobe M. Presence of tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline in foods: compound related to Parkinson's disease. Life Sci. (1988) 43 373-378.
26. Lorenc-Koci E., Sokołowska M., Włodek L. Effect of acute administration of 1,2,3,4-tetrahydroisoquinoline on the levels of glutathione and reactive oxygen species, and on the enzymatic activity of γ-glutamyl transpeptidase in dopaminergic structures of rat brain. Neuroscience (2001) 108 413-420.
27. Pelicano H., Carney D., Huang P. ROS stress in cancer cells and therapeutic implications. Drug Resist. Updat. (2004) 7 97-110.
28. Włodek L., Wróbel M., Czubak J. Transamination and transsulfuration of L-cysteine in Ehrlich ascites tumor cells and mouse liver. Int. J. Biochem. (1993) 25 107-112.
29. Musallam L., Ethier C., Haddad P.S., Denizeau F., Bilodeau M. Resistance to Fas-induced apoptosis in hepatocytes: role of GSH depletion by cell isolation and culture. Am. J. Physiol. Gastrointest. Liver Physiol. (2002) 283 G709-G718.
30. Berendji D., Kolb-Bachofen V., Meyer K.L., Kröncke K.D. Influence of nitric oxide on the intracellular reduced glutathione pool: different cellular capacities and strategies to encounter nitric oxide-mediated stress. Free Radic. Biol. Med. (1999) 27 773-780.
31. Paolicchi A., Lorenzini E., Perego P. et al. Extra-cellular thiol metabolism in clones of human metastatic melanoma with different gamma-glutamyl transpeptidase expression: implication for cell response to platinum-based drugs. Int. J. Cancer (2002) 97 740-745.
32. Zhang H., Forman H.J., Chio J. Gamma-glutamyl transpeptidase in glutathione biosynthesis. Meth. Enzymol. (2005) 401 468-483.
33. Daubeuf S., Balin D., Leroy P., Visvikis A. Different mechanism for c-glutamyltransferase-dependent resistance to carboplatin and cisplatin. Biochem. Pharmacol. (2003) 66 595-604.
34. Kröning R., Lichtenstein A.K., Nagami G.T. Sulfur-containing amino acids decrease cisplatin cytotoxicity and uptake in renal tubule epithelial cell lines. Cancer Chemother. Pharmacol. (2000) 45 43-49.
35. Hentze H., Schmitz I., Latta M., Krueger A., Krammer P.H., Wendel A. Glutathione dependence of caspase-8 activation at the death-inducing signaling complex. J. Biol. Chem. (2002) 277 5588-5595.
36. Luperchio S., Tamir S., Tannenbaum S.R. NO-induced oxidative stress and glutathione metabolism in rodent and human cells. Free Radic. Biol. Med. (1996) 21 513-519.
37. White A.C., Maloney E.K., Boustani M.R., Hassoun P.M., Fanburg B.L. Nitric oxide increases cellular glutathione levels in rat lung fibroblasts. Am. J. Respir. Cell Mol. Biol. (1995) 13 442-448.
38. Hothersall J.S., Cunha F.Q., Neild G.H., Norohna-Dutra A.A. Induction of nitric oxide synthesis in J774 cells lowers intracellular glutathione: effect of modulated glutathione redox status on nitric oxide synthase induction. Biochem. J. (1997) 322 477-481.
39. Kuo P.C., Abe K.Y. Nitric oxide-associated regulation of hepatocyte glutathione synthesis in a guanylyl cyclase-independent event. Surgery (1996) 120 309-314.
40. Dröge W., Eck H.P., Betzler M., Schlag P., Drings P., Ebert W. Plasma glutamate concentration and lymphocyte activity. J Cancer Res. Clin. Oncol. (1988) 14 124-128.
41. Tang C., Grimm E.A. Depletion of endogenous nitric oxide enhances cisplatin-induced apoptosis in a p53 dependent manner in melanoma cell lines. J. Biol. Chem. (2004) 279 288-298.
42. Mohr S., Zech B, Lepetina E.G., Brüne B. Inhibition of caspase-3 by S-nitrosation and oxidation caused by nitric oxide. Biochem. Biophys. Res. Commun. (1997) 238 387-391.
43. Broillet M.C. S-nitrosylation of protein. Cell. Mol. Life Sci. (1999) 55 1036-1042.
44. Gaston B. Nitric oxide and thiol groups. Biochim. Biophys. Acta (1999) 1411 323-333.
45. Jourd'heuil D., Jourd'heuil F.L., Feelisch M. Oxidation and nitrosation of thiols at low micromolar exposure to nitric oxide. J. Biol. Chem. (2003) 278 15720-15726.